VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-20.62%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$365M
AUM Growth
+$365M
(+9.9%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
33.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Adverum Biotechnologies
ADVM
|
$69.1M |
| 2 |
Akero Therapeutics
AKRO
|
$58M |
Top Sells
| 1 |
Vivani Medical
VANI
|
$3.91M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.71B
| $177M | 48.6% | 4,205,615 | – | – |
|
|
2
Adverum Biotechnologies
ADVM
$64.6M
| $69.1M | 18.94% | +7,068,233 | New | +$69.1M |
|
|
3
Akero Therapeutics
AKRO
$3.74B
| $58M | 15.91% | +2,736,572 | New | +$58M |
|
4
Veracyte
VCYT
$2.39B
| $29.3M | 8.04% | 1,205,407 | – | – |
|
|
GRTS
5
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $18.1M | 4.95% | 3,102,929 | – | – |
|
6
Ocular Therapeutix
OCUL
$2.12B
| $11M | 3.01% | 2,215,384 | – | – |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $805K | 0.22% | 543,753 | – | – |
|
|
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
| $648K | 0.18% | 101,855 | – | – |
|
|
9
Vivani Medical
VANI
$68.1M
| $559K | 0.15% | 561,612 -3,931,363 | -88% | -$3.91M |
|